Universe Pharmaceuticals Inc. (UPC) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 8.71M | 9.15M | 10.14M | 12.88M | 13.84M | 18.47M | 15.94M | 24.2M | 23.69M | 24.29M | 15.35M | 15.35M | 16.61M | 14.26M |
| Revenue Growth % | -14.14% | -28.96% | -26.74% | -30.23% | -13.17% | -23.7% | -32.71% | -0.37% | 54.31% | 58.24% | -7.6% | - | 16.54% | - |
| Cost of Goods Sold | 5.57M | 5.99M | 7.31M | 9.64M | 9.78M | 12.45M | 7.89M | 10.57M | 10.42M | 12.42M | 8.31M | 8.31M | 9.91M | 7.55M |
| COGS % of Revenue | 63.97% | 65.43% | 72.12% | 74.82% | 70.64% | 67.43% | 49.48% | 43.67% | 44.01% | 51.14% | 54.1% | 54.1% | 59.65% | 52.97% |
| Gross Profit | 3.14M | 3.16M | 2.83M | 3.24M | 4.06M | 6.01M | 8.05M | 13.63M | 13.26M | 11.87M | 7.05M | 7.05M | 6.7M | 6.7M |
| Gross Margin % | 36.03% | 34.57% | 27.88% | 25.18% | 29.36% | 32.57% | 50.52% | 56.33% | 55.99% | 48.86% | 45.9% | 45.9% | 40.35% | 47.03% |
| Gross Profit Growth % | 10.94% | -2.47% | -30.42% | -46.05% | -49.54% | -55.88% | -39.29% | 14.84% | 88.23% | 68.45% | 5.12% | - | -0.01% | - |
| Operating Expenses | 3.73M | 5.49M | 9.11M | 4.98M | 7.74M | 5.87M | 17.98M | 10.93M | 9.45M | 2.29M | 1.87M | 1.87M | 1.83M | 1.88M |
| OpEx % of Revenue | 42.8% | 59.99% | 89.81% | 38.69% | 55.91% | 31.76% | 112.79% | 45.17% | 39.89% | 9.42% | 12.19% | 12.19% | 11% | 13.16% |
| Selling, General & Admin | 3.15M | 5.39M | 5.59M | 4.85M | 5.06M | 3.55M | -18.58M | 10.72M | 4.17M | 1.91M | 1.4M | 1.4M | 1.52M | 1.48M |
| SG&A % of Revenue | 36.19% | 58.94% | 55.15% | 37.66% | 36.54% | 19.23% | -116.54% | 44.29% | 17.62% | 7.86% | 9.1% | 9.1% | 9.14% | 10.39% |
| Research & Development | 574.92K | 96.84K | 2.96M | 86.5K | 2.61M | 2.29M | 7.49M | 134.46K | 5.03M | 320.55K | 291.56K | 291.56K | 309.22K | 394.69K |
| R&D % of Revenue | 6.6% | 1.06% | 29.16% | 0.67% | 18.87% | 12.39% | 46.98% | 0.56% | 21.23% | 1.32% | 1.9% | 1.9% | 1.86% | 2.77% |
| Other Operating Expenses | 0 | 0 | 558.67K | 45.8K | 68.79K | 26.8K | 1000K | 77.24K | 246.05K | 57.99K | 182.88K | 182.88K | 0 | 0 |
| Operating Income | -589.16K | -2.33M | -6.28M | -1.74M | -3.68M | 149.25K | -10.14M | 2.7M | 4.01M | 9.58M | 5.17M | 5.17M | 4.88M | 4.83M |
| Operating Margin % | -6.77% | -25.42% | -61.93% | -13.51% | -26.56% | 0.81% | -63.61% | 11.16% | 16.92% | 39.45% | 33.71% | 33.71% | 29.35% | 33.87% |
| Operating Income Growth % | 90.62% | -33.71% | -70.83% | -1265.92% | 63.75% | -94.47% | -353.04% | -71.81% | -22.56% | 85.18% | 6.12% | - | 1% | - |
| EBITDA | -341.37K | -2.06M | -6.04M | -1.49M | -3.43M | 407.03K | -9.9M | 2.99M | 4.21M | 9.83M | 5.38M | 5.38M | 5.09M | 5.05M |
| EBITDA Margin % | -3.92% | -22.48% | -59.59% | -11.57% | -24.74% | 2.2% | -62.09% | 12.37% | 17.77% | 40.45% | 35.04% | 35.04% | 30.61% | 35.45% |
| EBITDA Growth % | 94.35% | -37.94% | -76.43% | -466.38% | 65.4% | -86.4% | -335.07% | -69.54% | -21.73% | 82.65% | 5.79% | - | 0.62% | - |
| D&A (Non-Cash Add-back) | 247.79K | 269.64K | 236.87K | 248.86K | 251K | 257.78K | 241.84K | 292.11K | 203.41K | 243.47K | 205.04K | 205.04K | 209.21K | 226.37K |
| EBIT | -284K | -3.16M | 4.46M | -12.3M | -4.06M | 333.5K | -11.26M | 3.4M | 4.17M | 9.57M | 5.11M | 5.11M | 4.89M | 4.84M |
| Net Interest Income | -103.3K | -128.75K | -141.56K | -136.61K | -82.22K | 92.36K | -74.01K | 608.04K | 184.62K | -46.67K | -61.88K | -61.88K | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 166.93K | 0 | 696.43K | 239.55K | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 103.3K | 128.75K | 141.56K | 136.61K | 82.22K | 74.57K | 74.01K | 88.39K | 54.93K | 46.67K | 61.88K | 61.88K | 64.63K | 82.46K |
| Other Income/Expense | 201.86K | -957.99K | 10.6M | -10.7M | -463.56K | 109.69K | -1.19M | 608.67K | 112.41K | -54.89K | -124.7K | -124.7K | -49.88K | -69.14K |
| Pretax Income | -387.3K | -3.28M | 4.32M | -12.44M | -4.14M | 258.93K | -11.33M | 3.31M | 4.12M | 9.53M | 5.05M | 5.05M | 4.83M | 4.76M |
| Pretax Margin % | -4.45% | -35.89% | 42.56% | -96.52% | -29.91% | 1.4% | -71.09% | 13.68% | 17.39% | 39.22% | 32.9% | 32.9% | 29.05% | 33.38% |
| Income Tax | 0 | 0 | -58.44K | 665.15K | 1.34M | 974.36K | -825.8K | 1.58M | -52.22K | 2.41M | 1.27M | 1.27M | 1.05M | 957.56K |
| Effective Tax Rate % | 0% | 0% | -1.35% | -5.35% | -32.35% | 376.3% | 7.29% | 47.68% | -1.27% | 25.3% | 25.17% | 25.17% | 21.77% | 20.12% |
| Net Income | -387.3K | -3.28M | 4.37M | -13.1M | -5.45M | -715.43K | -10.47M | 1.73M | 4.17M | 7.15M | 3.78M | 3.78M | 3.78M | 3.8M |
| Net Margin % | -4.45% | -35.89% | 43.14% | -101.68% | -39.36% | -3.87% | -65.67% | 7.16% | 17.61% | 29.42% | 24.62% | 24.62% | 22.73% | 26.66% |
| Net Income Growth % | -108.85% | 74.93% | 180.29% | -1731.28% | 47.96% | -141.31% | -350.91% | -75.77% | 10.4% | 89.14% | 0.09% | - | -0.68% | - |
| Net Income (Continuing) | -387.3K | -3.28M | 4.37M | -13.1M | -5.48M | -715.43K | -10.51M | 1.73M | 4.17M | 7.12M | 3.78M | 3.78M | 3.78M | 3.8M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.69 | -944.40 | 719.79 | -2155.91 | -919.74 | -120.79 | -1767.40 | 292.37 | 791.38 | 1355.80 | 647.85 | 647.85 | 647.27 | 651.68 |
| EPS Growth % | -100.1% | 56.19% | 178.26% | -1684.84% | 47.96% | -141.31% | -323.33% | -78.44% | 22.15% | 109.28% | 0.09% | - | -0.68% | - |
| EPS (Basic) | -0.69 | -944.40 | 719.79 | -2155.91 | -919.74 | -120.79 | -1767.40 | 292.37 | 791.38 | 1355.80 | 647.85 | 647.85 | 647.27 | 651.68 |
| Diluted Shares Outstanding | 563.34K | 3.48K | 6.08K | 6.08K | 5.92K | 5.92K | 5.92K | 5.92K | 5.27K | 5.27K | 5.83K | 5.83K | 5.83K | 5.83K |
| Basic Shares Outstanding | 563.34K | 3.48K | 6.08K | 6.08K | 5.92K | 5.92K | 5.92K | 5.92K | 5.27K | 5.27K | 5.83K | 5.83K | 5.83K | 5.83K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | 211.95% | 40.25% |